Background: The clinical efficacy and safety of vaccination against novel coronavirus disease 2019 (COVID-19) in patients with cirrhosis have not been evaluated yet.
Aim: To evaluate the clinical efficacy and safety of vaccination against COVID-19 in patients with cirrhosis.
Methods: This was a retrospective cohort study of patients with cirrhosis.